Cite
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors.
MLA
Yoneshima, Yasuto, et al. “HTLV-1 Seropositive Patients with Lung Cancer Treated with PD-1 Inhibitors.” Cancer Science, vol. 111, no. 9, Sept. 2020, pp. 3395–96. EBSCOhost, https://doi.org/10.1111/cas.14536.
APA
Yoneshima, Y., Kato, K., Minami, H., Ikeda, M., Watanabe, H., Yoshimoto, G., Miyamoto, T., Akashi, K., Nakanishi, Y., & Okamoto, I. (2020). HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors. Cancer Science, 111(9), 3395–3396. https://doi.org/10.1111/cas.14536
Chicago
Yoneshima, Yasuto, Koji Kato, Haruna Minami, Munehiko Ikeda, Hiroyuki Watanabe, Goichi Yoshimoto, Toshihiro Miyamoto, Koichi Akashi, Yoichi Nakanishi, and Isamu Okamoto. 2020. “HTLV-1 Seropositive Patients with Lung Cancer Treated with PD-1 Inhibitors.” Cancer Science 111 (9): 3395–96. doi:10.1111/cas.14536.